Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

FDG-PET Adapted Sequential Therapy With Brentuximab Vedotin and Augmented ICE Followed By Autologous Stem Cell Transplant For Relapsed and Refractory Hodgkin Lymphoma

Alison Moskowitz, MD, Heiko Schoder, MD, John F. Gerecitano, MD, PhD, Paul Hamlin, MD, Steven M. Horwitz, MD, Matthew J Matasar, MD, MS, Vahakn S Keskinyan, Susan McCall, Ariela Noy, MD, M. Lia Palomba, MD, Carol S. Portlock, MD, David J Straus, MD, Joachim Yahalom, MD, Anas Younes, MD, Andrew D Zelenetz, MD, PhD, Craig H. Moskowitz, MD

Blood (2013) 122 (21): 2099.

https://doi.org/10.1182/blood.V122.21.2099.2099

Published: 2013

Journal Articles

Semi-Quantitative Evaluation of Pre-Transplant FDG-PET in Relapsed and Refractory Hodgkin Lymphoma

Alison Moskowitz, MD, Jocelyn C Maragulia, Anita Kumar, MD, Craig H. Moskowitz, MD

Blood (2012) 120 (21): 2015.

https://doi.org/10.1182/blood.V120.21.2015.2015

Published: 2012

Journal Articles

Clinicopathologic Features, Prognosis, and Therapeutic Responses in Patients with Granulomatous Mycosis Fungoides: A Single Center Experience From Memorial Sloan Kettering Cancer Center.

Janet Y. Li, BA, Melissa Pulitzer, MD, Patricia L. Myskowski, MD, Steven Dusza, Dr.PH, Steven M. Horwitz, MD, Alison Moskowitz, MD, Christiane Querfeld, MD, PhD

Blood (2012) 120 (21): 2643.

https://doi.org/10.1182/blood.V120.21.2643.2643

Published: 2012

Journal Articles

Pralatrexate in Relapsed/Refractory HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia: A New York City Multi-Institutional Experience.

Matthew A Lunning, DO, Jason Gonsky, MD, PhD, Jia Ruan, MD, PhD, Adrienne A. Phillips, MD, MPH, Melissa Pulitzer, MD, Alison Moskowitz, MD, Christiane Querfeld, MD PhD, Patricia L Myskowski, M.D., Ariela Noy, MD, Steven M. Horwitz, MD

Blood (2012) 120 (21): 2735.

https://doi.org/10.1182/blood.V120.21.2735.2735

Published: 2012

Journal Articles

CD30 Is a Potential Therapeutic Target in Patients with HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma Presenting Outside of Japan.

Matthew A Lunning, DO, April Chiu, M.D., Julie Teruya Feldstein, MD, Jocelyn C. Maragulia, Alison Moskowitz, MD, Matthew J. Matasar, MD, MS, David J. Straus, MD, Ariela Noy, MD, Patricia L Myskowski, M.D., Andrew D. Zelenetz, MD, PhD, Steven M. Horwitz, MD

Blood (2012) 120 (21): 2706.

https://doi.org/10.1182/blood.V120.21.2706.2706

Published: 2012

Journal Articles

Outcomes for Patients Who Fail High Dose Chemoradiotherapy and Autologous Stem Cell Rescue for Relapsed and Primary Refractory Hodgkin Lymphoma.

Alison Moskowitz, MD, Joachim Yahalom, MD, Tarun Kewalramani, MD, Manfred Tejerina, Andrew D. Zelenetz, MD PhD, Craig H. Moskowitz, MD

Blood (2007) 110 (11): 1649.

https://doi.org/10.1182/blood.V110.11.1649.1649

Published: 2007

NARROW

FDG-PET Adapted Sequential Therapy With Brentuximab Vedotin and Augmented ICE Followed By Autologous Stem Cell Transplant For Relapsed and Refractory Hodgkin Lymphoma

Semi-Quantitative Evaluation of Pre-Transplant FDG-PET in Relapsed and Refractory Hodgkin Lymphoma

Clinicopathologic Features, Prognosis, and Therapeutic Responses in Patients with Granulomatous Mycosis Fungoides: A Single Center Experience From Memorial Sloan Kettering Cancer Center.

Pralatrexate in Relapsed/Refractory HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia: A New York City Multi-Institutional Experience.

CD30 Is a Potential Therapeutic Target in Patients with HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma Presenting Outside of Japan.

Outcomes for Patients Who Fail High Dose Chemoradiotherapy and Autologous Stem Cell Rescue for Relapsed and Primary Refractory Hodgkin Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

FDG-PET Adapted Sequential Therapy With Brentuximab Vedotin and Augmented ICE Followed By Autologous Stem Cell Transplant For Relapsed and Refractory Hodgkin Lymphoma

Semi-Quantitative Evaluation of Pre-Transplant FDG-PET in Relapsed and Refractory Hodgkin Lymphoma

Clinicopathologic Features, Prognosis, and Therapeutic Responses in Patients with Granulomatous Mycosis Fungoides: A Single Center Experience From Memorial Sloan Kettering Cancer Center.

Pralatrexate in Relapsed/Refractory HTLV-1 Associated Adult T-Cell Lymphoma/Leukemia: A New York City Multi-Institutional Experience.

CD30 Is a Potential Therapeutic Target in Patients with HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma Presenting Outside of Japan.

Outcomes for Patients Who Fail High Dose Chemoradiotherapy and Autologous Stem Cell Rescue for Relapsed and Primary Refractory Hodgkin Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only